Sirtuins and their relevance to the kidney

Journal of the American Society of Nephrology

Volumn 21, Issue 10, 2010, Pages 1620-1627

  Hao, Chuan Ming ^a   Haase, Volker H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANTIDIABETIC AGENT; ENZYME ACTIVATOR; EXTRACHROMOSOMAL DNA; MONO ADP RIBOSYLTRANSFERASE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RESVERATROL; RIBOSOME DNA; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; SIRTUIN; SIRTUIN 1; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; SIRTUIN ACTIVATOR; SODIUM; TRANSCRIPTION FACTOR FKHRL1; TRANSFERASE; UNCLASSIFIED DRUG; ERYTHROPOIETIN;

AGING; CALORIC RESTRICTION; CELL SURVIVAL; CELL VIABILITY; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DNA DAMAGE; ENZYME ACTIVITY; ENZYME REGULATION; FIBROGENESIS; GENE DOSAGE; GLOMERULOSCLEROSIS; HOMOLOGOUS RECOMBINATION; HUMAN; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RENAL PROTECTION; SACCHAROMYCES CEREVISIAE; SHORT SURVEY; SIGNAL TRANSDUCTION; SODIUM URINE LEVEL; ANIMAL; ANOXIA; BIOSYNTHESIS; BLOOD PRESSURE; KIDNEY DISEASES; METABOLISM; PHYSIOLOGY;

ANIMALS; ANOXIA; BLOOD PRESSURE; CALORIC RESTRICTION; ERYTHROPOIETIN; HUMANS; KIDNEY; KIDNEY DISEASES; SIRTUINS; SODIUM;

EID: 77957883314     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010010046     Document Type: Short Survey

References (105)

1. McCay CM, Crowell MF: Prolonging the life span. The Scientific Monthly 39: 405-414, 1934
2. Barger JL, Walford RL, Weindruch R: The retardation of aging by caloric restriction: Its significance in the transgenic era. Exp Gerontol 38: 1343-1351, 2003
3. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R: Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325: 201-204, 2009
4. Bishop NA, Guarente L: Genetic links between diet and lifespan: Shared mechanisms from yeast to humans. Nat Rev Genet 8: 835-844, 2007
5. Piper MD, Bartke A: Diet and aging. Cell Metab 8: 99-104, 2008
6. Campisi J, Yaswen P: Aging and cancer cell biology, 2009. Aging Cell 8: 221-225, 2009
7. Stern JS, Gades MD, Wheeldon CM, Borchers AT: Calorie restriction in obesity: Prevention of kidney disease in rodents. J Nutr 131: 913S-917S, 2001
8. Davis TA, Bales CW, Beauchene RE: Differential effects of dietary caloric and protein restriction in the aging rat. Exp Gerontol 18: 427-435, 1983
9. Weindruch R: The retardation of aging by caloric restriction: Studies in rodents and primates. Toxicol Pathol 24: 742-745, 1996
10. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH: Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 105: 9793-9798, 2008
11. Joseph J, Cole G, Head E, Ingram D: Nutrition, brain aging, and neurodegeneration. J Neurosci 29: 12795-12801, 2009
12. Sinclair DA, Guarente L: Extrachromosomal rDNA circles - a cause of aging in yeast. Cell 91: 1033-1042, 1997
13. Kaeberlein M, McVey M, Guarente L: The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13: 2570-2580, 1999
14. Tissenbaum HA, Guarente L: Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410: 227-230, 2001
15. Rogina B, Helfand SL: Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 101: 15998-16003, 2004
16. Lin SJ, Kaeberlein M, Andalis AA, Sturtz LA, Defossez PA, Culotta VC, Fink GR, Guarente L: Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 418: 344-348, 2002 (Pubitemid 34790687)
17. Lamming DW, Latorre-Esteves M, Medvedik O, Wong SN, Tsang FA, Wang C, Lin SJ, Sinclair DA: HST2 mediates SIR2-independent life-span extension by calorie restriction. Science 309: 1861-1864, 2005
18. Kaeberlein M, Powers RW 3rd, Steffen KK, Westman EA, Hu D, Dang N, Kerr EO, Kirkland KT, Fields S, Kennedy BK: Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310: 1193-1196, 2005
19. Kaeberlein M, Kirkland KT, Fields S, Kennedy BK: Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol 2: E296, 2004
20. Fabrizio P, Gattazzo C, Battistella L, Wei M, Cheng C, McGrew K, Longo VD: Sir2 blocks extreme life-span extension. Cell 123: 655-667, 2005
21. Yang H, Lavu S, Sinclair DA: Nampt/PBEF/Visfatin: A regulator of mammalian health and longevity? Exp Gerontol 41: 718-726, 2006
22. Imai S: The NAD World: A new systemic regulatory network for metabolism and aging - Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem Biophys 53: 65-74, 2009
23. Michan S, Sinclair D: Sirtuins in mammals: Insights into their biological function. Biochem J 404: 1-13, 2007
24. Chen D, Steele AD, Lindquist S, Guarente L: Increase in activity during calorie restriction requires Sirt1. Science 310: 1641, 2005
25. Boily G, Seifert EL, Bevilacqua L, He XH, Sabourin G, Estey C, Moffat C, Crawford S, Saliba S, Jardine K, Xuan J, Evans M, Harper ME, McBurney MW: SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS ONE 3: e1759, 2008
26. Bordone L, Cohen D, Robinson A, Motta MC, van Veen E, Czopik A, Steele AD, Crowe H, Marmor S, Luo J, Gu W, Guarente L: SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6: 759-767, 2007
27. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW, Guarente L: Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429: 771-776, 2004
28. Milne JC, Denu JM: The Sirtuin family: Therapeutic targets to treat diseases of aging. Curr Opin Chem Biol 12: 11-17, 2008
29. Yang H, Baur JA, Chen A, Miller C, Adams JK, Kisielewski A, Howitz KT, Zipkin RE, Sinclair DA: Design and synthesis of compounds that extend yeast replicative lifespan. Aging Cell 6: 35-43, 2007
30. Epstein M: Aging and the kidney. J Am Soc Nephrol 7: 1106-1122, 1996
31. Nangaku M, Izuhara Y, Usuda N, Inagi R, Shibata T, Sugiyama S, Kurokawa K, van Ypersele de Strihou C, Miyata T: In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nephrol Dial Transplant 20: 2661-2669, 2005
32. Klar AJ, Fogel S, Macleod K: MAR1-a Regulator of the HMa and HMalpha Loci in SACCHAROMYCES CEREVISIAE. Genetics 93: 37-50, 1979
33. Rine J, Herskowitz I: Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae. Genetics 116: 9-22, 1987
34. Gottlieb S, Esposito RE: A new role for a yeast transcriptional silencer gene, SIR2, in regulation of recombination in ribosomal DNA. Cell 56: 771-776, 1989
35. Aparicio OM, Billington BL, Gottschling DE: Modifiers of position effect are shared between telomeric and silent mating-type loci in S. cerevisiae. Cell 66: 1279-1287, 1991
36. Braunstein M, Rose AB, Holmes SG, Allis CD, Broach JR: Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev 7: 592-604, 1993
37. Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, Sternglanz R: The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci U S A 97: 5807-5811, 2000
38. Imai S, Armstrong CM, Kaeberlein M, Guarente L: Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403: 795-800, 2000
39. Landry J, Slama JT, Sternglanz R: Role of NAD(+) in the deacetylase activity of the SIR2-like proteins. Biochem Biophys Res Commun 278: 685-690, 2000
40. Tanner KG, Landry J, Sternglanz R, Denu JM: Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci U S A 97: 14178-14182, 2000
41. Liszt G, Ford E, Kurtev M, Guarente L: Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem 280: 21313-21320, 2005
42. Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos GD, Karow M, Blander G, Wolberger C, Prolla TA, Weindruch R, Alt FW, Guarente L: SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126: 941-954, 2006
43. Belenky P, Bogan KL, Brenner C: NAD+ metabolism in health and disease. Trends Biochem Sci 32: 12-19, 2007
44. Frye RA: Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 260: 273-279, 1999
45. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I: Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16: 4623-4635, 2005
46. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E: The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11: 437-444, 2003
47. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA: Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305: 390-392, 2004
48. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P: Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113-118, 2005
49. Nemoto S, Fergusson MM, Finkel T: Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306: 2105-2108, 2004
50. Zhang Q, Wang SY, Fleuriel C, Leprince D, Rocheleau JV, Piston DW, Goodman RH: Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc Natl Acad Sci U S A 104: 829-833, 2007
51. Abdelmohsen K, Pullmann R Jr., Lal A, Kim HH, Galban S, Yang X, Blethrow JD, Walker M, Shubert J, Gillespie DA, Furneaux H, Gorospe M: Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25: 543-557, 2007
52. Yamakuchi M, Ferlito M, Lowenstein CJ: miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 105: 13421-13426, 2008
53. Yang Y, Fu W, Chen J, Olashaw N, Zhang X, Nicosia SV, Bhalla K, Bai W: SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat Cell Biol 9: 1253-1262, 2007
54. Sasaki T, Maier B, Koclega KD, Chruszcz M, Gluba W, Stukenberg PT, Minor W, Scrable H: Phosphorylation regulates SIRT1 function. PLoS One 3: e4020, 2008
55. Ford J, Ahmed S, Allison S, Jiang M, Milner J: JNK2-dependent regulation of SIRT1 protein stability. Cell Cycle 7: 3091-3097, 2008
56. Zschoernig B, Mahlknecht U: Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2. Biochem Biophys Res Commun 381: 372-377, 2009
57. Kim JE, Chen J, Lou Z: DBC1 is a negative regulator of SIRT1. Nature 451: 583-586, 2008
58. Kim EJ, Kho JH, Kang MR, Um SJ: Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 28: 277-290, 2007
59. Zhang T, Berrocal JG, Frizzell KM, Gamble MJ, DuMond ME, Krishnakumar R, Yang T, Sauve AA, Kraus WL: Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem 284: 20408-20417, 2009
60. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I: Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14: 1431-1437, 1994
61. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426-430, 2005 (Pubitemid 40139988)
62. Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimburger O, Barany P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P: Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype GFR, body composition, and survival in patients with CKD. Am J Kidney Dis 49: 237-244, 2007
63. Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, Sonmez A, Cakir E, Yenicesu M, Lindholm B, Stenvinkel P, Axelsson J: Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol Dial Transplant 23: 959-965, 2008 (Pubitemid 351767576)
64. Song HK, Lee MH, Kim BK, Park YG, Ko GJ, Kang YS, Han JY, Han SY, Han KH, Kim HK, Cha DR: Visfatin: A new player in mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol 295: F1485-F1494, 2008
65. Crujeiras AB, Parra D, Goyenechea E, Martinez JA: Sirtuin gene expression in human mononuclear cells is modulated by caloric restriction. Eur J Clin Invest 38: 672-678, 2008
66. Civitarese AE, Carling S, Heilbronn LK, Hulver MH, Ukropcova B, Deutsch WA, Smith SR, Ravussin E: Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 4: e76, 2007
67. Pedersen SB, Olholm J, Paulsen SK, Bennetzen MF, Richelsen B: Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women. Int J Obes (Lond), 32: 1250-1255, 2008
68. Tikoo K, Tripathi DN, Kabra DG, Sharma V, Gaikwad AB: Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53. FEBS Lett 581: 1071-1078, 2007
69. Frescas D, Valenti L, Accili D: Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 280: 20589-20595, 2005
70. Qiao L, Shao J: SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J Biol Chem 281: 39915-39924, 2006
71. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA: Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342, 2006
72. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ, Westphal CH: Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712-716, 2007
73. Banks AS, Kon N, Knight C, Matsumoto M, Gutierrez-Juarez R, Rossetti L, Gu W, Accili D: SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab 8: 333-341, 2008
74. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122, 2006
75. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME: Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015, 2004
76. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA: hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159, 2001
77. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W: Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148, 2001
78. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L: Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551-563, 2004
79. Higami Y, Shimokawa I: Apoptosis in the aging process. Cell Tissue Res 301: 125-132, 2000
80. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J: Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100: 1512-1521, 2007
81. Hsu CP, Odewale I, Alcendor RR, Sadoshima J: Sirt1 protects the heart from aging and stress. Biol Chem 389: 221-231, 2008
82. Lee JH, Song MY, Song EK, Kim EK, Moon WS, Han MK, Park JW, Kwon KB, Park BH: Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 58: 344-351, 2009
83. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA: Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159: 993-1002, 2009
84. Westerheide SD, Anckar J, Stevens SM Jr., Sistonen L, Morimoto RI: Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323: 1063-1066, 2009
85. Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB: Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123: 437-448, 2005
86. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, Chua KF: Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A 100: 10794-10799, 2003
87. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23: 2369-2380, 2004
88. Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, Miller C, Frye R, Ploegh H, Kessler BM, Sinclair DA: Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 13: 627-638, 2004
89. Jeong J, Juhn K, Lee H, Kim SH, Min BH, Lee KM, Cho MH, Park GH, Lee KH: SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp Mol Med 39: 8-13, 2007
90. Chander V, Chopra K: Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats. Arch Med Res 37: 19-26, 2006 (Pubitemid 41727886)
91. Bertelli AA, Migliori M, Panichi V, Origlia N, Filippi C, Das DK, Giovannini L: Resveratrol, a component of wine and grapes, in the prevention of kidney disease. Ann N Y Acad Sci 957: 230-238, 2002
92. Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isono M, Isshiki K, Uzu T, Kashiwagi A, Koya D: Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic Biol Med 40: 2175-2182, 2006
93. Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Washida N, Tokuyama H, Hayashi K, Itoh H: Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem Biophys Res Commun 372: 51-56, 2008
94. Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isshiki K, Isono M, Uzu T, Guarente L, Kashiwagi A, Koya D: SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J Biol Chem 282: 151-158, 2007
95. Hao CM, Yull F, Blackwell T, Komhoff M, Davis LS, Breyer MD: Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. J Clin Invest 106: 973-982, 2000
96. Pallone TL: Is oxidative stress differentially regulated in the renal cortex and medulla? Nat Clin Pract Nephrol 2: 118-119, 2006
97. Burg MB, Ferraris JD, Dmitrieva NI: Cellular response to hyperosmotic stresses. Physiol Rev 87: 1441-1474, 2007
98. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP: Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med 16: 235-251, 1987
99. Subcommittee on Nonpharmacological Therapy of the 1984 Joint National Committee on Detection, E, and Treatment of High Blood Pressure: Nonpharmacological approaches to the control of high blood pressure. Hypertension 8: 444-467, 1986
100. Group, HPTR: The Hypertension Prevention Trial: Three-year effects of dietary changes on blood pressure. Arch Intern Med 150: 153-162, 1990
101. Miyazaki R, Ichiki T, Hashimoto T, Inanaga K, Imayama I, Sadoshima J, Sunagawa K: SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 28: 1263-1269, 2008
102. Zhang D, Li S, Cruz P, Kone BC: Sirtuin 1 functionally and physically interacts with disruptor of telomeric silencing-1 to regulate alpha-ENaC transcription in collecting duct. J Biol Chem 284: 20917-20926, 2009
103. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, Irani K: SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 104: 14855-14860, 2007
104. Haase VH: Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 291: F271-F281, 2006
105. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, Garcia JA: Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 324: 1289-1293, 2009